Howell Peyton R 4
4 · TANDEM DIABETES CARE INC · Filed May 10, 2022
Insider Transaction Report
Form 4
Howell Peyton R
Director
Transactions
- Purchase
Common Stock
2022-05-06$75.21/sh+100$7,521→ 1,048 total - Purchase
Common Stock
2022-05-06$74.56/sh+17$1,268→ 1,065 total - Purchase
Common Stock
2022-05-06$74.60/sh+500$37,300→ 1,565 total - Purchase
Common Stock
2022-05-06$74.58/sh+483$36,022→ 2,948 total - Purchase
Common Stock
2022-05-06$75.21/sh+400$30,084→ 1,965 total - Purchase
Common Stock
2022-05-06$75.00/sh+500$37,500→ 2,465 total